Commodore Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-885,000
| Closed | -$17M | – | 39 |
|
|
2024
Q3 | $17M | Buy |
885,000
+60,000
| +7% | +$1.16M | 1.06% | 27 |
|
|
2024
Q2 | $16.9M | Buy |
825,000
+506,149
| +159% | +$10.4M | 1.16% | 24 |
|
|
2024
Q1 | $7.59M | Buy |
+318,851
| New | +$7.59M | 0.51% | 33 |
|
|
2023
Q4 | – | Sell |
-957,509
| Closed | -$13.9M | – | 37 |
|
|
2023
Q3 | $13.9M | Sell |
957,509
-40,087
| -4% | -$582K | 1.63% | 21 |
|
|
2023
Q2 | $20.9M | Buy |
997,596
+143,712
| +17% | +$3.01M | 2.35% | 15 |
|
|
2023
Q1 | $18M | Buy |
853,884
+165,439
| +24% | +$3.49M | 2.75% | 12 |
|
|
2022
Q4 | $17.5M | Sell |
688,445
-49,665
| -7% | -$1.26M | 2.64% | 15 |
|
|
2022
Q3 | $17.7M | Buy |
+738,110
| New | +$17.7M | 2.85% | 13 |
|
|
2021
Q2 | – | Sell |
-236,500
| Closed | -$5.29M | – | 31 |
|
|
2021
Q1 | $5.29M | Sell |
236,500
-93,815
| -28% | -$2.1M | 2.11% | 22 |
|
|
2020
Q4 | $7.35M | Buy |
+330,315
| New | +$7.35M | 3.99% | 11 |
|